Clinical Trials Browser

OTHER × Prostatic Neoplasms × sacituzumab govitecan × Clear all

NCT03725761 2025-05-13

Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy

Phase 2 Active not recruiting

31 enrolled 12 charts

Prostatic Neoplasms